Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study.

MLA

Nolè, F., et al. “Vinorelbine, Cisplatin and Continuous Infusion of 5-Fluorouracil (ViFuP) in Metastatic Breast Cancer Patients: A Phase II Study.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 12, no. 1, Jan. 2001, pp. 95–100. EBSCOhost, https://doi.org/10.1023/a:1008334227668.

APA

Nolè, F., Munzone, E., Mandalà, M., Catania, C., Orlando, L., Zampino, M. G., Minchella, I., Colleoni, M., Peruzzotti, G., Marrocco, E., & Goldhirsch, A. (2001). Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: a phase II study. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 12(1), 95–100. https://doi.org/10.1023/a:1008334227668

Chicago

Nolè, F, E Munzone, M Mandalà, C Catania, L Orlando, M G Zampino, I Minchella, et al. 2001. “Vinorelbine, Cisplatin and Continuous Infusion of 5-Fluorouracil (ViFuP) in Metastatic Breast Cancer Patients: A Phase II Study.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 12 (1): 95–100. doi:10.1023/a:1008334227668.